Regarding cytotoxic T response markers, CLE/SLE + patients had a significantly higher number of cells marked with Granzyme B and Perforin (Table 3) than CLE/SLE- patients (ARC: p = 0.0097; SLICC-12: p = 0.0148). The gene discussed is PRF1; the disease is systemic lupus erythematosus.